The Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP), commonly known as the PM Jan Aushadhi Yojana, is a revolutionary initiative by the Government of India aimed at making quality medicines available at affordable prices to all, especially the poor and underprivileged. Launched in 2008 and significantly revamped in 2015 under Prime Minister Narendra Modi’s leadership, this scheme has become one of the key pillars of India’s public health strategy.

Background and Need for the Scheme

India has long struggled with the high cost of healthcare. Branded medicines, which dominate the pharmaceutical market, are often unaffordable for large sections of the population. According to several reports, out-of-pocket expenditure on healthcare in India is among the highest in the world, with medicines accounting for a significant portion of this expense. This situation often forces people to either delay treatment or fall into debt traps to afford necessary medical care.

Objectives of the PM Jan Aushadhi Yojana

• To make quality medicines available to all at affordable prices.
• To reduce healthcare expenditure for every citizen.
• To create awareness among the public about generic medicines.
• To generate employment opportunities by encouraging entrepreneurs to open Jan Aushadhi Kendras.

Implementation and Administration

The Bureau of Pharma PSUs of India (BPPI), under the Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, is responsible for implementing the scheme. BPPI procures generic medicines from certified suppliers and ensures their distribution through a nationwide network of Jan Aushadhi Kendras.

These Kendras are retail outlets where generic medicines are sold to the public at significantly lower prices than their branded counterparts. The government ensures that the medicines sold through these stores meet strict quality standards by sourcing them from WHO-GMP certified manufacturers.

Features of PM Jan Aushadhi Yojana

• Affordable Medicines: Generic medicines sold under this scheme are up to 50-90% cheaper than branded drugs.
• Widespread Network: As of 2025, there are over 10,000 Jan Aushadhi Kendras across India.
• Wide Range of Products: The scheme covers over 1,600 drugs and 250 surgical and medical devices.
• High Quality: All medicines are tested in NABL-accredited laboratories to ensure their safety and efficacy.
• Digital Platform: An online Jan Aushadhi Sugam app helps users locate nearby Kendras and check the availability of medicines.

Comparative Advantage Over Branded Medicines

Generic medicines have the same active ingredients, strength, dosage form, and route of administration as branded medicines. The only difference is in the price. The PMBJP ensures that these medicines are manufactured in reputable facilities and undergo rigorous quality testing. This dispels the myth that lower price means lower quality.

For example, a branded tablet for high blood pressure may cost ₹100 for 10 tablets, while the same generic medicine under the Jan Aushadhi Yojana may cost just ₹10. This massive price difference can significantly lower the overall cost of treatment, especially for patients with long-term health conditions.

Challenges and Limitations

Despite its many advantages, the PM Jan Aushadhi Yojana faces certain challenges:

• Awareness: A large segment of the population is still unaware of the availability and benefits of generic medicines.
• Prescribing Practices: Many doctors continue to prescribe branded medicines, partly due to aggressive marketing by pharmaceutical companies.
• Stock Availability: Some Kendras report occasional stockouts or delays in the supply chain.
• Location: While urban areas are well-covered, remote and rural areas still lack adequate number of Jan Aushadhi stores.

Government Initiatives to Overcome Challenges

The government is continuously working to address these issues. Steps include:

• Launching awareness campaigns through media and community outreach programs.
• Encouraging doctors to prescribe generic medicines through guidelines and policy interventions.
• Improving logistics and inventory management systems to reduce stockouts.
• Offering higher incentives for opening Kendras in backward and rural regions.

Future Roadmap

The government aims to expand the reach of Jan Aushadhi Kendras to every block and tehsil in the country. The long-term vision includes:

• Digitization of the entire supply chain for better efficiency.
• Inclusion of more medicines and devices under the scheme.
• Integration with health insurance schemes to enhance accessibility.
• Collaboration with state governments and local bodies for wider outreach.

Conclusion

The PM Jan Aushadhi Yojana is a powerful step toward realizing the dream of “Health for All.” By providing high-quality generic medicines at affordable prices, the scheme is not just saving money for consumers but also saving lives. With continued support from the government, healthcare professionals, and the public, this initiative has the potential to redefine India’s healthcare landscape and set a model for other countries to follow.